» Authors » L M Aledort

L M Aledort

Explore the profile of L M Aledort including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 200
Citations 1748
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aledort L
Haemophilia . 2016 Jun; 22(5):676-83. PMID: 27354149
The establishment of dedicated comprehensive treatment centres more than a half century ago transformed the management of haemophilia in the United States. Formerly, a disease associated with crippling disability and...
2.
Schwartz J, Aledort L, Seremetis S
Haemophilia . 2016 May; 3(1):24-30. PMID: 27214615
Progression to clinical liver failure has been observed in hepatitis C (HCV)-infected, HIV-seropositive haemophiliacs. We studied the records of 176 haemophiliacs who were infected with HIV and/or HCV seen between...
3.
Aledort L
Haemophilia . 2016 May; 3 Suppl 3:31. PMID: 27213874
No abstract available.
4.
Aledort L
Haemophilia . 2016 May; 3 Suppl 3:2. PMID: 27213870
No abstract available.
5.
Aledort L, Hay C
Haemophilia . 2016 May; 3 Suppl 3:1. PMID: 27213869
No abstract available.
6.
Auerswald G, Kurnik K, Aledort L, Chehadeh H, Loew-Baselli A, Steinitz K, et al.
Haemophilia . 2015 Apr; 21(5):622-8. PMID: 25912619
Introduction: Inhibitory antibodies to factor VIII occur in about 30% of previously untreated patients (PUPs) and are the most serious complication of haemophilia A. It is unclear why some patients...
7.
8.
Oldenburg J, Jimenez-Yuste V, Peiro-Jordan R, Aledort L, Santagostino E
Haemophilia . 2013 Dec; 20(1):83-91. PMID: 24354480
Most studies on immune tolerance induction (ITI) therapy in haemophilia A patients are focused on primary ITI in children. Here we report on the ITI outcome in a large retrospective...
9.
Aledort L
Haemophilia . 2011 Nov; 18(2):246-7. PMID: 22103479
My comments on the implication of the vW molecule in down-regulating the immunogenicity of factor VIII.
10.
Aledort L, Navickis R, Wilkes M
J Thromb Haemost . 2011 Sep; 9(11):2325-7. PMID: 21880112
No abstract available.